Way of Diagnosing PH in Common Heart Test Gets FDA Support
Related Articles
Anumana’s ECG Pulmonary Hypertension AI Algorithm Gains Breakthrough Status
Medical Product Outsourcing: Artificial intelligence (AI)-driven healthtech company, Anumana has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for its AI-enhanced, ECG-based pulmonary hypertension (PH) early detection algorithm.…{post_date: F d, Y}
Anumana Names Dr. Simos Kedikoglou President & COO
AI Tech 365: Anumana, a leading AI-driven health technology company, announced the appointment of Dr. Simos Kedikoglou as President and Chief Operating Officer (COO), effective immediately.{post_date: F d, Y}
Mayo Clinic, Janssen-backed venture gets FDA OK for pulmonary hypertension AI algorithm
Becker's Hospital Review: A Mayo Clinic and Janssen-backed venture has received FDA breakthrough designation for an algorithm designed to enable early detection of pulmonary hypertension. Anumana Inc. received the breakthrough…{post_date: F d, Y}
Mayo-developed AI detects heart condition from Apple Watch ECGs
Modern Healthcare: An artificial-intelligence algorithm developed at Mayo Clinic could identify left ventricular dysfunction—or a weak heart pump—in most patients based on Apple Watch data, researchers shared at a conference…{post_date: F d, Y}